Show
Sort by
-
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
- Journal Article
- A1
- open access
Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials
-
- Journal Article
- A1
- open access
Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort
-
- Journal Article
- A1
- open access
Cluster analysis of inflammatory biomarker expression in the international severe asthma registry
-
- Journal Article
- A1
- open access
Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma
-
- Journal Article
- A1
- open access
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
- Journal Article
- A1
- open access
International severe asthma registry (ISAR) : protocol for a global registry
-
- Journal Article
- A1
- open access
International severe asthma registry mission statement
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
- Journal Article
- A1
- open access
The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies
-
- Journal Article
- A1
- open access
Quality standards in respiratory real-life effectiveness research : the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
-
- Journal Article
- A1
- open access
Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases